

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.76263921 |
| 2 | DNA deamination (GO:0045006) | 6.58588011 |
| 3 | viral transcription (GO:0019083) | 5.67150862 |
| 4 | translational termination (GO:0006415) | 5.44489089 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 5.41777712 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.13257089 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 5.00706123 |
| 8 | chaperone-mediated protein transport (GO:0072321) | 4.99311535 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 4.98580945 |
| 10 | protein targeting to ER (GO:0045047) | 4.98379888 |
| 11 | translational elongation (GO:0006414) | 4.89671587 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 4.72848495 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.70216366 |
| 14 | ribosomal large subunit biogenesis (GO:0042273) | 4.59020546 |
| 15 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.58967280 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.40652447 |
| 17 | viral life cycle (GO:0019058) | 4.33685997 |
| 18 | translational initiation (GO:0006413) | 4.33631533 |
| 19 | cellular protein complex disassembly (GO:0043624) | 4.30348584 |
| 20 | proteasome assembly (GO:0043248) | 4.29961072 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.16534493 |
| 22 | ATP synthesis coupled proton transport (GO:0015986) | 4.16534493 |
| 23 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.15299678 |
| 24 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.14191220 |
| 25 | translation (GO:0006412) | 4.11052502 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.96936111 |
| 27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.90651064 |
| 28 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.89479094 |
| 29 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.82774645 |
| 30 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.80504945 |
| 31 | protein complex disassembly (GO:0043241) | 3.73245080 |
| 32 | DNA strand elongation (GO:0022616) | 3.68717188 |
| 33 | telomere maintenance via recombination (GO:0000722) | 3.67674964 |
| 34 | formation of translation preinitiation complex (GO:0001731) | 3.66263022 |
| 35 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.64706451 |
| 36 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.64706451 |
| 37 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.60129008 |
| 38 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.59608474 |
| 39 | deoxyribonucleotide catabolic process (GO:0009264) | 3.57969990 |
| 40 | macromolecular complex disassembly (GO:0032984) | 3.57420312 |
| 41 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.57113054 |
| 42 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.56720879 |
| 43 | negative regulation of ligase activity (GO:0051352) | 3.56494452 |
| 44 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.56494452 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.53886226 |
| 46 | cytochrome complex assembly (GO:0017004) | 3.52136516 |
| 47 | regulation of mitochondrial translation (GO:0070129) | 3.47932611 |
| 48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.47824405 |
| 49 | deoxyribose phosphate catabolic process (GO:0046386) | 3.45944442 |
| 50 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.43997569 |
| 51 | GDP-mannose metabolic process (GO:0019673) | 3.42905652 |
| 52 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.40271871 |
| 53 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.40271871 |
| 54 | oxidative phosphorylation (GO:0006119) | 3.39864039 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.39845786 |
| 56 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.39007709 |
| 57 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.39007709 |
| 58 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.39007709 |
| 59 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.36844440 |
| 60 | termination of RNA polymerase III transcription (GO:0006386) | 3.36216605 |
| 61 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.36216605 |
| 62 | protein localization to mitochondrion (GO:0070585) | 3.35492863 |
| 63 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.34226980 |
| 64 | rRNA processing (GO:0006364) | 3.33541854 |
| 65 | cellular component biogenesis (GO:0044085) | 3.33254422 |
| 66 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.32471549 |
| 67 | spliceosomal snRNP assembly (GO:0000387) | 3.31715513 |
| 68 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.30144145 |
| 69 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.30144145 |
| 70 | respiratory chain complex IV assembly (GO:0008535) | 3.28340157 |
| 71 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.26687219 |
| 72 | respiratory electron transport chain (GO:0022904) | 3.25156830 |
| 73 | GTP biosynthetic process (GO:0006183) | 3.25039269 |
| 74 | mitotic recombination (GO:0006312) | 3.23590132 |
| 75 | base-excision repair, AP site formation (GO:0006285) | 3.23342623 |
| 76 | protein targeting to membrane (GO:0006612) | 3.22382501 |
| 77 | rRNA metabolic process (GO:0016072) | 3.21325279 |
| 78 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.20607382 |
| 79 | protein maturation by protein folding (GO:0022417) | 3.19971711 |
| 80 | electron transport chain (GO:0022900) | 3.18327455 |
| 81 | purine nucleotide salvage (GO:0032261) | 3.17819298 |
| 82 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.17616329 |
| 83 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.15011703 |
| 84 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.12061314 |
| 85 | pseudouridine synthesis (GO:0001522) | 3.11773882 |
| 86 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.10576911 |
| 87 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.10316865 |
| 88 | telomere maintenance via telomere lengthening (GO:0010833) | 3.09871352 |
| 89 | negative regulation of B cell apoptotic process (GO:0002903) | 3.09797402 |
| 90 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.09108660 |
| 91 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.08652367 |
| 92 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.08605040 |
| 93 | nucleotide salvage (GO:0043173) | 3.08154988 |
| 94 | protein neddylation (GO:0045116) | 3.07994355 |
| 95 | rRNA modification (GO:0000154) | 3.07160528 |
| 96 | mRNA catabolic process (GO:0006402) | 3.00143007 |
| 97 | chromatin remodeling at centromere (GO:0031055) | 2.99552715 |
| 98 | CENP-A containing nucleosome assembly (GO:0034080) | 2.99393481 |
| 99 | deoxyribose phosphate metabolic process (GO:0019692) | 2.99143873 |
| 100 | positive regulation of ligase activity (GO:0051351) | 2.98319707 |
| 101 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.97664389 |
| 102 | 7-methylguanosine mRNA capping (GO:0006370) | 2.96896418 |
| 103 | protein targeting to mitochondrion (GO:0006626) | 2.96661481 |
| 104 | ribosome biogenesis (GO:0042254) | 2.94720405 |
| 105 | purine nucleobase biosynthetic process (GO:0009113) | 2.94342665 |
| 106 | peptidyl-histidine modification (GO:0018202) | 2.93737548 |
| 107 | UTP biosynthetic process (GO:0006228) | 2.92452394 |
| 108 | mitochondrial transport (GO:0006839) | 2.91733193 |
| 109 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.90889897 |
| 110 | metallo-sulfur cluster assembly (GO:0031163) | 2.90808706 |
| 111 | iron-sulfur cluster assembly (GO:0016226) | 2.90808706 |
| 112 | RNA catabolic process (GO:0006401) | 2.90653416 |
| 113 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.90554142 |
| 114 | RNA capping (GO:0036260) | 2.90356082 |
| 115 | 7-methylguanosine RNA capping (GO:0009452) | 2.90356082 |
| 116 | protein complex biogenesis (GO:0070271) | 2.89770238 |
| 117 | establishment of protein localization to mitochondrion (GO:0072655) | 2.89564976 |
| 118 | inner mitochondrial membrane organization (GO:0007007) | 2.88488863 |
| 119 | DNA replication initiation (GO:0006270) | 2.87960760 |
| 120 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.86396538 |
| 121 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.85269843 |
| 122 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.85269843 |
| 123 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.85016200 |
| 124 | viral mRNA export from host cell nucleus (GO:0046784) | 2.84536564 |
| 125 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.84177006 |
| 126 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.84177006 |
| 127 | nucleoside salvage (GO:0043174) | 2.82737151 |
| 128 | nucleobase biosynthetic process (GO:0046112) | 2.81951492 |
| 129 | spliceosomal complex assembly (GO:0000245) | 2.81897247 |
| 130 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.81149134 |
| 131 | positive regulation of cell cycle arrest (GO:0071158) | 2.79801153 |
| 132 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.79268215 |
| 133 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.78389234 |
| 134 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.78387789 |
| 135 | cytidine metabolic process (GO:0046087) | 2.78369053 |
| 136 | cytidine catabolic process (GO:0006216) | 2.78369053 |
| 137 | cytidine deamination (GO:0009972) | 2.78369053 |
| 138 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.77811922 |
| 139 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.76635360 |
| 140 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76537238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.69974916 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.16955002 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.07914785 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.87725897 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.69691491 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.53875178 |
| 7 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.43278155 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.18390186 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.11613894 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.09023926 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.93275241 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.84260486 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.74577797 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.63730835 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.62411747 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55485741 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.55260521 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.46073127 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.42628883 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.39083021 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.37706160 |
| 22 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32639022 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.30245365 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.28887481 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.24183529 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.10495541 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.06001638 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05975819 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99656487 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.98961752 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94778109 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93225751 |
| 33 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.90230175 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.90162350 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88383546 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.88337928 |
| 37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.88204554 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81863052 |
| 39 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.78095887 |
| 40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.76502537 |
| 41 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.75758567 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69370734 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67456334 |
| 44 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65976780 |
| 45 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60847751 |
| 46 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58694465 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.56341680 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.54362349 |
| 49 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53368902 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.50969864 |
| 51 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48495402 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.46005845 |
| 53 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45837620 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45016353 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43243291 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.39019351 |
| 57 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.35725680 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32468176 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31394685 |
| 60 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.30450080 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29559211 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25508571 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24057839 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22005918 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20661508 |
| 66 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19318677 |
| 67 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17986838 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17947953 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16316758 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16283941 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16199379 |
| 72 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15372307 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12392290 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.10433575 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10291519 |
| 76 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08989129 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07012475 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06980042 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05335256 |
| 80 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04413350 |
| 81 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03891713 |
| 82 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.03267381 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02737483 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02680760 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01486486 |
| 86 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01084026 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00281135 |
| 88 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99906004 |
| 89 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.99768532 |
| 90 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99449659 |
| 91 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99216233 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98950467 |
| 93 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98621375 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97671352 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 0.97198999 |
| 96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.95836640 |
| 97 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94931848 |
| 98 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94857443 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 0.94832621 |
| 100 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93647686 |
| 101 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93618387 |
| 102 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93543403 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93193268 |
| 104 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93023359 |
| 105 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92545687 |
| 106 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.90945669 |
| 107 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90380256 |
| 108 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88527703 |
| 109 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.87814646 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87355721 |
| 111 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86838323 |
| 112 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.86770773 |
| 113 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86645849 |
| 114 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.86235690 |
| 115 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85412657 |
| 116 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.81867864 |
| 117 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81334717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.84402332 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.57291098 |
| 3 | MP0003111_abnormal_nucleus_morphology | 2.77605932 |
| 4 | MP0010094_abnormal_chromosome_stability | 2.72552432 |
| 5 | MP0003077_abnormal_cell_cycle | 2.67235234 |
| 6 | MP0003186_abnormal_redox_activity | 2.64255249 |
| 7 | MP0008007_abnormal_cellular_replicative | 2.62112128 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.57838086 |
| 9 | MP0008058_abnormal_DNA_repair | 2.38953523 |
| 10 | MP0003786_premature_aging | 2.30094309 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.19658120 |
| 12 | MP0006082_CNS_inflammation | 2.18237924 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.16055054 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.05205567 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.03884630 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.03427571 |
| 17 | MP0009785_altered_susceptibility_to | 2.02822440 |
| 18 | MP0000490_abnormal_crypts_of | 1.98751576 |
| 19 | MP0001790_abnormal_immune_system | 1.88811609 |
| 20 | MP0005387_immune_system_phenotype | 1.88811609 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.84506759 |
| 22 | MP0003646_muscle_fatigue | 1.74330632 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.66119590 |
| 24 | MP0008057_abnormal_DNA_replication | 1.64653863 |
| 25 | MP0002132_abnormal_respiratory_system | 1.54770400 |
| 26 | MP0003315_abnormal_perineum_morphology | 1.48243601 |
| 27 | MP0003075_altered_response_to | 1.47727299 |
| 28 | MP0005451_abnormal_body_composition | 1.47607552 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.44880838 |
| 30 | MP0000858_altered_metastatic_potential | 1.42782898 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.39701187 |
| 32 | MP0003436_decreased_susceptibility_to | 1.38803705 |
| 33 | MP0005671_abnormal_response_to | 1.38239466 |
| 34 | MP0000749_muscle_degeneration | 1.36802365 |
| 35 | MP0005025_abnormal_response_to | 1.32791755 |
| 36 | MP0009764_decreased_sensitivity_to | 1.32678325 |
| 37 | MP0004147_increased_porphyrin_level | 1.32659627 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.31825376 |
| 39 | MP0001853_heart_inflammation | 1.30830456 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.30449715 |
| 41 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30107810 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.28090247 |
| 43 | MP0005670_abnormal_white_adipose | 1.27814500 |
| 44 | MP0002019_abnormal_tumor_incidence | 1.27153178 |
| 45 | MP0000343_altered_response_to | 1.23887187 |
| 46 | MP0000313_abnormal_cell_death | 1.23781714 |
| 47 | MP0001730_embryonic_growth_arrest | 1.19516661 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.17863263 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.17828921 |
| 50 | MP0005379_endocrine/exocrine_gland_phen | 1.17269149 |
| 51 | MP0003718_maternal_effect | 1.17203702 |
| 52 | MP0005166_decreased_susceptibility_to | 1.17013370 |
| 53 | MP0002398_abnormal_bone_marrow | 1.16883255 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.15171693 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.15072911 |
| 56 | MP0003011_delayed_dark_adaptation | 1.15016925 |
| 57 | MP0000685_abnormal_immune_system | 1.14730457 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.14567381 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.14567381 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.13815007 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.13660632 |
| 62 | MP0003303_peritoneal_inflammation | 1.12069793 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 1.11634033 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11442446 |
| 65 | MP0001905_abnormal_dopamine_level | 1.10053209 |
| 66 | MP0000750_abnormal_muscle_regeneration | 1.09892932 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.09396808 |
| 68 | MP0002405_respiratory_system_inflammati | 1.09164817 |
| 69 | MP0002429_abnormal_blood_cell | 1.07753155 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.07423099 |
| 71 | MP0002722_abnormal_immune_system | 1.06682107 |
| 72 | MP0006054_spinal_hemorrhage | 1.06008798 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.05959321 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 1.05406240 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 1.05285507 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 1.03099689 |
| 77 | MP0002723_abnormal_immune_serum | 1.02974986 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 1.01982952 |
| 79 | MP0001819_abnormal_immune_cell | 1.01157347 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.01120493 |
| 81 | MP0009763_increased_sensitivity_to | 1.00612472 |
| 82 | MP0005332_abnormal_amino_acid | 1.00284010 |
| 83 | MP0003724_increased_susceptibility_to | 1.00160676 |
| 84 | MP0009697_abnormal_copulation | 0.99724115 |
| 85 | MP0000716_abnormal_immune_system | 0.98067370 |
| 86 | MP0001764_abnormal_homeostasis | 0.97089395 |
| 87 | MP0005165_increased_susceptibility_to | 0.96434393 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.95529129 |
| 89 | MP0001800_abnormal_humoral_immune | 0.94426099 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.94155132 |
| 91 | MP0000358_abnormal_cell_content/ | 0.93096710 |
| 92 | MP0008873_increased_physiological_sensi | 0.91441449 |
| 93 | MP0005310_abnormal_salivary_gland | 0.91413869 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.89911591 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89882091 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.89575967 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.89018828 |
| 98 | MP0002163_abnormal_gland_morphology | 0.88741986 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.88303338 |
| 100 | MP0009840_abnormal_foam_cell | 0.87812604 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.87002736 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.86671751 |
| 103 | MP0005330_cardiomyopathy | 0.86162703 |
| 104 | MP0001697_abnormal_embryo_size | 0.86014557 |
| 105 | MP0008469_abnormal_protein_level | 0.85919478 |
| 106 | MP0002080_prenatal_lethality | 0.85873956 |
| 107 | MP0002419_abnormal_innate_immunity | 0.85442845 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.84872492 |
| 109 | MP0005408_hypopigmentation | 0.84760104 |
| 110 | MP0008995_early_reproductive_senescence | 0.83230913 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.81396052 |
| 112 | MP0003941_abnormal_skin_development | 0.79899976 |
| 113 | MP0003195_calcinosis | 0.79556764 |
| 114 | MP0003172_abnormal_lysosome_physiology | 0.79138231 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.77939988 |
| 116 | MP0002638_abnormal_pupillary_reflex | 0.76969990 |
| 117 | MP0003123_paternal_imprinting | 0.76861938 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.76797310 |
| 119 | MP0005360_urolithiasis | 0.76639892 |
| 120 | MP0001873_stomach_inflammation | 0.76365819 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.75353459 |
| 122 | MP0002933_joint_inflammation | 0.74872890 |
| 123 | MP0003448_altered_tumor_morphology | 0.74188244 |
| 124 | MP0002938_white_spotting | 0.73628206 |
| 125 | MP0003984_embryonic_growth_retardation | 0.72443507 |
| 126 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72350310 |
| 127 | MP0002160_abnormal_reproductive_system | 0.72161215 |
| 128 | MP0005636_abnormal_mineral_homeostasis | 0.72132022 |
| 129 | MP0001672_abnormal_embryogenesis/_devel | 0.70676486 |
| 130 | MP0005380_embryogenesis_phenotype | 0.70676486 |
| 131 | MP0008877_abnormal_DNA_methylation | 0.69878706 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.69862426 |
| 133 | MP0001542_abnormal_bone_strength | 0.69765344 |
| 134 | MP0003866_abnormal_defecation | 0.69113763 |
| 135 | MP0005389_reproductive_system_phenotype | 0.68898635 |
| 136 | MP0002088_abnormal_embryonic_growth/wei | 0.68140773 |
| 137 | MP0001663_abnormal_digestive_system | 0.67621611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.66845303 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.39126596 |
| 3 | Reticulocytopenia (HP:0001896) | 5.11197694 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.51038834 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.36759782 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.12688849 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.05936555 |
| 8 | Hepatic necrosis (HP:0002605) | 3.96424844 |
| 9 | Increased CSF lactate (HP:0002490) | 3.92251516 |
| 10 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.85872242 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.85414732 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.84022782 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.84022782 |
| 14 | Macrocytic anemia (HP:0001972) | 3.63052110 |
| 15 | Acute encephalopathy (HP:0006846) | 3.61394326 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.58883450 |
| 17 | Pallor (HP:0000980) | 3.50245983 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.47345869 |
| 19 | Exertional dyspnea (HP:0002875) | 3.43499799 |
| 20 | Increased serum lactate (HP:0002151) | 3.37409781 |
| 21 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.34732460 |
| 22 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.26394268 |
| 23 | Aplastic anemia (HP:0001915) | 3.24311461 |
| 24 | Exercise intolerance (HP:0003546) | 3.14637320 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 2.92611134 |
| 26 | Lactic acidosis (HP:0003128) | 2.85104773 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 2.84706913 |
| 28 | 11 pairs of ribs (HP:0000878) | 2.79875706 |
| 29 | Carpal bone hypoplasia (HP:0001498) | 2.76611081 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 2.75103697 |
| 31 | Oral leukoplakia (HP:0002745) | 2.74182063 |
| 32 | Respiratory failure (HP:0002878) | 2.69728251 |
| 33 | Increased muscle lipid content (HP:0009058) | 2.69088576 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.65784247 |
| 35 | Cerebral edema (HP:0002181) | 2.58843758 |
| 36 | Breast hypoplasia (HP:0003187) | 2.53462803 |
| 37 | Thrombocytosis (HP:0001894) | 2.49705792 |
| 38 | Rough bone trabeculation (HP:0100670) | 2.49355992 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.48342541 |
| 40 | Poor head control (HP:0002421) | 2.45957745 |
| 41 | Birth length less than 3rd percentile (HP:0003561) | 2.45794702 |
| 42 | Microretrognathia (HP:0000308) | 2.45266850 |
| 43 | Respiratory difficulties (HP:0002880) | 2.43153624 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40719185 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40719185 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40719185 |
| 47 | Microvesicular hepatic steatosis (HP:0001414) | 2.39502406 |
| 48 | Progressive muscle weakness (HP:0003323) | 2.31670783 |
| 49 | Degeneration of anterior horn cells (HP:0002398) | 2.30805745 |
| 50 | Abnormality of the anterior horn cell (HP:0006802) | 2.30805745 |
| 51 | Obstructive lung disease (HP:0006536) | 2.26500498 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26500498 |
| 53 | Cleft eyelid (HP:0000625) | 2.26462494 |
| 54 | Multiple enchondromatosis (HP:0005701) | 2.25522474 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.21987024 |
| 56 | Trismus (HP:0000211) | 2.21917642 |
| 57 | Testicular atrophy (HP:0000029) | 2.17225747 |
| 58 | Abnormal hemoglobin (HP:0011902) | 2.15783505 |
| 59 | Irregular epiphyses (HP:0010582) | 2.15730078 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.15333229 |
| 61 | Petechiae (HP:0000967) | 2.13209456 |
| 62 | Ragged-red muscle fibers (HP:0003200) | 2.11594079 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.09812079 |
| 64 | Nausea (HP:0002018) | 2.09452699 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.08759526 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.07870858 |
| 67 | Increased IgM level (HP:0003496) | 2.07402485 |
| 68 | IgG deficiency (HP:0004315) | 2.04294910 |
| 69 | Glycosuria (HP:0003076) | 2.04219159 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.04219159 |
| 71 | Abnormality of reticulocytes (HP:0004312) | 2.04011027 |
| 72 | Pancytopenia (HP:0001876) | 2.00933033 |
| 73 | Abnormal glycosylation (HP:0012345) | 1.98984191 |
| 74 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98984191 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98984191 |
| 76 | Abnormal protein glycosylation (HP:0012346) | 1.98984191 |
| 77 | Absent thumb (HP:0009777) | 1.96925760 |
| 78 | Stomatitis (HP:0010280) | 1.96007431 |
| 79 | Rhabdomyolysis (HP:0003201) | 1.93463034 |
| 80 | Recurrent abscess formation (HP:0002722) | 1.92863463 |
| 81 | Abnormality of renal resorption (HP:0011038) | 1.89452415 |
| 82 | Methylmalonic aciduria (HP:0012120) | 1.89426125 |
| 83 | Increased serum ferritin (HP:0003281) | 1.89060070 |
| 84 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.88957625 |
| 85 | Optic disc pallor (HP:0000543) | 1.88679900 |
| 86 | Hepatosplenomegaly (HP:0001433) | 1.87732423 |
| 87 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87136687 |
| 88 | CNS demyelination (HP:0007305) | 1.85834825 |
| 89 | Hyperphosphaturia (HP:0003109) | 1.85365079 |
| 90 | Patent foramen ovale (HP:0001655) | 1.85237001 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84505174 |
| 92 | Hypertensive crisis (HP:0100735) | 1.84484256 |
| 93 | Muscle fiber atrophy (HP:0100295) | 1.84204550 |
| 94 | Abnormal trabecular bone morphology (HP:0100671) | 1.83711016 |
| 95 | Recurrent bacterial skin infections (HP:0005406) | 1.82155636 |
| 96 | Vomiting (HP:0002013) | 1.81715500 |
| 97 | Opisthotonus (HP:0002179) | 1.81361163 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 1.80860484 |
| 99 | Gliosis (HP:0002171) | 1.77974466 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 1.76533868 |
| 101 | B lymphocytopenia (HP:0010976) | 1.76361578 |
| 102 | Secondary amenorrhea (HP:0000869) | 1.76137817 |
| 103 | Progressive neurologic deterioration (HP:0002344) | 1.76096795 |
| 104 | Palpitations (HP:0001962) | 1.75737536 |
| 105 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.75703726 |
| 106 | Premature graying of hair (HP:0002216) | 1.75688213 |
| 107 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.74158075 |
| 108 | Severe combined immunodeficiency (HP:0004430) | 1.74060659 |
| 109 | Neoplasm of the adrenal gland (HP:0100631) | 1.74031203 |
| 110 | Cerebral hypomyelination (HP:0006808) | 1.73686764 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 1.73420854 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.73420854 |
| 113 | Lethargy (HP:0001254) | 1.72982156 |
| 114 | Neutropenia (HP:0001875) | 1.72914258 |
| 115 | Patellar aplasia (HP:0006443) | 1.72574184 |
| 116 | Abnormality of the prostate (HP:0008775) | 1.72225250 |
| 117 | Acute hepatic failure (HP:0006554) | 1.72134295 |
| 118 | Cerebral palsy (HP:0100021) | 1.72065877 |
| 119 | Sparse eyelashes (HP:0000653) | 1.69433498 |
| 120 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.69159377 |
| 121 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.68925800 |
| 122 | Abnormality of the preputium (HP:0100587) | 1.67024628 |
| 123 | Type 2 muscle fiber atrophy (HP:0003554) | 1.66115692 |
| 124 | IgM deficiency (HP:0002850) | 1.64603878 |
| 125 | Emotional lability (HP:0000712) | 1.63821508 |
| 126 | Vertebral compression fractures (HP:0002953) | 1.62040979 |
| 127 | Bone marrow hypocellularity (HP:0005528) | 1.61777646 |
| 128 | Genu varum (HP:0002970) | 1.61462938 |
| 129 | Abnormality of T cell physiology (HP:0011840) | 1.59265146 |
| 130 | Triphalangeal thumb (HP:0001199) | 1.57513812 |
| 131 | Chromsome breakage (HP:0040012) | 1.54281797 |
| 132 | Pulmonary fibrosis (HP:0002206) | 1.54189575 |
| 133 | Redundant skin (HP:0001582) | 1.53905951 |
| 134 | Leukodystrophy (HP:0002415) | 1.53296621 |
| 135 | Hyperalaninemia (HP:0003348) | 1.51784191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.70655048 |
| 2 | BUB1 | 4.42284820 |
| 3 | VRK2 | 4.09167701 |
| 4 | STK16 | 3.52490913 |
| 5 | EIF2AK1 | 2.65785266 |
| 6 | WEE1 | 2.65174151 |
| 7 | TESK1 | 2.52704100 |
| 8 | PIM2 | 2.47831386 |
| 9 | TLK1 | 2.22878779 |
| 10 | SRPK1 | 2.17590832 |
| 11 | MST4 | 2.07953256 |
| 12 | PBK | 1.96740614 |
| 13 | PLK4 | 1.96687611 |
| 14 | EIF2AK3 | 1.88793367 |
| 15 | TESK2 | 1.87619892 |
| 16 | VRK1 | 1.82606815 |
| 17 | KDR | 1.78295909 |
| 18 | MYLK | 1.63917871 |
| 19 | ZAK | 1.61813070 |
| 20 | NME1 | 1.61527694 |
| 21 | BCKDK | 1.59924161 |
| 22 | TAOK3 | 1.57690171 |
| 23 | RPS6KA4 | 1.54388547 |
| 24 | IRAK3 | 1.53798649 |
| 25 | BRSK2 | 1.51835021 |
| 26 | CDK19 | 1.50539491 |
| 27 | MAP3K11 | 1.48355659 |
| 28 | ACVR1B | 1.42344550 |
| 29 | PRKG2 | 1.38570903 |
| 30 | CDC7 | 1.29643299 |
| 31 | MAP4K2 | 1.28495120 |
| 32 | IRAK4 | 1.26549523 |
| 33 | AURKB | 1.25193396 |
| 34 | BRAF | 1.20088254 |
| 35 | LIMK1 | 1.17001361 |
| 36 | RPS6KB2 | 1.15827322 |
| 37 | PLK1 | 1.14552593 |
| 38 | MKNK1 | 1.14203437 |
| 39 | OBSCN | 1.12304379 |
| 40 | DAPK1 | 1.10016154 |
| 41 | PDK2 | 1.06372137 |
| 42 | MAP4K1 | 1.06188962 |
| 43 | DYRK3 | 1.04958335 |
| 44 | MKNK2 | 1.04792780 |
| 45 | AURKA | 1.04365847 |
| 46 | STK38L | 1.04313571 |
| 47 | TBK1 | 1.03363887 |
| 48 | NEK2 | 1.03156606 |
| 49 | GRK7 | 1.03152359 |
| 50 | BLK | 1.01786446 |
| 51 | BRSK1 | 1.01223453 |
| 52 | TNK2 | 0.99867093 |
| 53 | STK24 | 0.97616369 |
| 54 | CDK7 | 0.96147009 |
| 55 | ILK | 0.95579019 |
| 56 | LRRK2 | 0.94602425 |
| 57 | GRK6 | 0.94515037 |
| 58 | PIM1 | 0.93564127 |
| 59 | ABL2 | 0.92740027 |
| 60 | TTK | 0.91111785 |
| 61 | IKBKE | 0.90998051 |
| 62 | IKBKB | 0.90813888 |
| 63 | NUAK1 | 0.88445794 |
| 64 | MAP3K12 | 0.84364314 |
| 65 | ARAF | 0.82904800 |
| 66 | CCNB1 | 0.81041443 |
| 67 | ATR | 0.80954343 |
| 68 | FLT3 | 0.80102901 |
| 69 | STK4 | 0.77716173 |
| 70 | NEK9 | 0.77650004 |
| 71 | PASK | 0.76476770 |
| 72 | ZAP70 | 0.76254882 |
| 73 | CDK8 | 0.75875653 |
| 74 | TEC | 0.75395304 |
| 75 | CDK4 | 0.75273442 |
| 76 | EIF2AK2 | 0.74291545 |
| 77 | CSNK2A1 | 0.73220381 |
| 78 | CHEK2 | 0.73127018 |
| 79 | BMPR2 | 0.71918890 |
| 80 | PIK3CA | 0.71499040 |
| 81 | MAP3K8 | 0.70855686 |
| 82 | PAK4 | 0.70593296 |
| 83 | PAK1 | 0.70165131 |
| 84 | BTK | 0.69068172 |
| 85 | ADRBK2 | 0.67975255 |
| 86 | CSNK1G3 | 0.67809176 |
| 87 | PIK3CG | 0.64226216 |
| 88 | RPS6KA5 | 0.63780697 |
| 89 | FES | 0.63330678 |
| 90 | TYK2 | 0.63008549 |
| 91 | DAPK3 | 0.60952870 |
| 92 | ITK | 0.60691093 |
| 93 | MAP3K3 | 0.60433508 |
| 94 | SCYL2 | 0.59614416 |
| 95 | NEK1 | 0.59477916 |
| 96 | PRKCI | 0.59282272 |
| 97 | JAK3 | 0.58352645 |
| 98 | MAP2K2 | 0.57819929 |
| 99 | TXK | 0.57422483 |
| 100 | KIT | 0.54583502 |
| 101 | SYK | 0.51938597 |
| 102 | EPHA2 | 0.51936517 |
| 103 | ERN1 | 0.51161978 |
| 104 | TAOK2 | 0.49818044 |
| 105 | CSNK2A2 | 0.49736478 |
| 106 | PRKCQ | 0.49668480 |
| 107 | MAP2K6 | 0.48849283 |
| 108 | MATK | 0.48418384 |
| 109 | DYRK2 | 0.47576547 |
| 110 | CSF1R | 0.47510973 |
| 111 | STK10 | 0.46145413 |
| 112 | TGFBR1 | 0.45764601 |
| 113 | PLK3 | 0.45272753 |
| 114 | MAP2K3 | 0.42827888 |
| 115 | GRK5 | 0.41952107 |
| 116 | MAPKAPK2 | 0.41605249 |
| 117 | MAP3K14 | 0.41488823 |
| 118 | LMTK2 | 0.40888321 |
| 119 | CLK1 | 0.40742532 |
| 120 | LCK | 0.40410180 |
| 121 | MAPKAPK3 | 0.40065106 |
| 122 | LYN | 0.38056941 |
| 123 | IRAK1 | 0.38028716 |
| 124 | RIPK4 | 0.37097460 |
| 125 | RPS6KA6 | 0.35267311 |
| 126 | SMG1 | 0.34576812 |
| 127 | MARK3 | 0.34496567 |
| 128 | MAP3K5 | 0.34397038 |
| 129 | CSNK1A1L | 0.34266293 |
| 130 | GRK1 | 0.33259200 |
| 131 | MUSK | 0.31038137 |
| 132 | PKN1 | 0.30495617 |
| 133 | TAOK1 | 0.29319239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.13548355 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.19365911 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.00242691 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.20312044 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.15229495 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.02703582 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.88254647 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.57732462 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.52455053 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.39169581 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.37114001 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.35749074 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.34994356 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.29523832 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.24875554 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.92455051 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.89972718 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.82190208 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.71318643 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49496130 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.48787339 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42623502 |
| 23 | Cell cycle_Homo sapiens_hsa04110 | 1.42179815 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34767914 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33890113 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32897932 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32609833 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32431641 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.31758363 |
| 30 | RNA degradation_Homo sapiens_hsa03018 | 1.31000255 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23189520 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21195729 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12414315 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06822250 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02231052 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99109342 |
| 37 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97870145 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96427021 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94759465 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91677112 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 0.89314908 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86727384 |
| 43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86603018 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86571796 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82653955 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82653172 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80379512 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75797342 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73404998 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71465750 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70838128 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70586441 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67451650 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 0.66209070 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65226440 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.64939835 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.64374095 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63750185 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63188483 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61257516 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60404583 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57959099 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57485588 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56183915 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55232458 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54665674 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54609076 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53971337 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53771237 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52936300 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51815365 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51779103 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51407965 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51152309 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51129232 |
| 76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50130281 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49799518 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49715430 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48972498 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48904424 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48877463 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48670840 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48435271 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.48033157 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48025548 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47352534 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45844015 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43685194 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43595641 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.43575623 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.42602784 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41860267 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41694564 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41199761 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40821902 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37597173 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35323247 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34619602 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33966878 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.33744721 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.33625241 |
| 102 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33460283 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32287260 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.31963121 |
| 105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31806960 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.31354061 |
| 107 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.29900682 |
| 108 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29398040 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28874244 |
| 110 | Malaria_Homo sapiens_hsa05144 | 0.28123060 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.27924863 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26728802 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26541506 |
| 114 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25983497 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25551763 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25423585 |
| 117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23745653 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22503556 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19095552 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.17828298 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17682256 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.17269622 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16526512 |
| 124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.16040747 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15618346 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.15006031 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13438916 |

